Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL15575285

Cc1ccc2[nH]c(=O)n(C3CCNCC3)c2c1.O=C(O)C(F)(F)F

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 4/20 0.54
CHRM2 P08172 2/20 0.54
CHRM4 P08173 1/20 0.54
CHRM5 P08912 1/20 0.54
CHRM3 P20309 1/20 0.54
KCNH2 Q12809 1/20 0.54
PGR P06401 9/20 0.46
OPRM1 P35372 6/20 0.46
OPRD1 P41143 3/20 0.46
OPRK1 P41145 3/20 0.46
CACNA1F O60840 2/20 0.46
ADRA1D P25100 2/20 0.46
HTR7 P34969 2/20 0.46
ADRA1A P35348 2/20 0.46
ADRA1B P35368 2/20 0.46
OPRL1 P41146 2/20 0.46
CACNA1D Q01668 2/20 0.46
CACNA1S Q13698 2/20 0.46
CACNA1C Q13936 2/20 0.46
TNKS O95271 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL15574954 0.91 OPRM1 (0.48) CHRM1CHRM2CHRM4CHRM5CHRM3
SCHEMBL603514 0.89 CHRM1 (0.64) CHRM1CHRM2CHRM4CHRM5CHRM3
Hydrochloric Acid SCHEMBL4635789 0.88 CHRM1 (0.62) CHRM1CHRM2CHRM4CHRM5CHRM3
Trifluoroacetic Acid SCHEMBL4932146 0.82 CHRM1 (0.82) CHRM1CHRM2CHRM4CHRM5CHRM3
SCHEMBL4748990 0.82 CHRM1 (0.58) CHRM1CHRM2CHRM4CHRM5CHRM3
Trifluoroacetic Acid SCHEMBL15575354 0.79 OPRM1 (0.51) OPRM1OPRD1OPRK1TNKSPARP1
SCHEMBL1760904 0.79 OPRM1 (0.57) CHRM1CHRM2CHRM4CHRM5CHRM3
SCHEMBL4749395 0.79 CHRM1 (0.64) CHRM1CHRM2CHRM4CHRM5CHRM3
Trifluoroacetic Acid SCHEMBL4436898 0.78 OPRM1 (0.52) CHRM1KCNH2OPRM1DRD2DRD3
SCHEMBL607235 0.78 OPRM1 (0.53) CHRM1CHRM2CHRM4CHRM5CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9505749-B2 Quinazolinone compounds and derivatives thereof AMGEN INC. (US) 2016-11-29 US disclosed
US-20150225396-A1 Quinazolinone Compounds and Derivatives Thereof AMGEN INC. 2015-08-13 US disclosed
EP-2890696-A1 QUINAZOLINONE COMPOUNDS AND DERIVATIVES THEREOF AMGEN, INC. (US) 2015-07-08 EP disclosed
WO-2014036022-A1 QUINAZOLINONE COMPOUNDS AND DERIVATIVES THEREOF AMGEN INC. (US) 2014-03-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150225396-A1 Quinazolinone Compounds and Derivatives Thereof TNKS, TPI1, TNKS1BP1 CHRM1 4446/4885CHRM2 4810/4885CHRM4 4741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.